68Ga-DOTATOC PET/CT 发现神经内分泌肿瘤假阴性:一例高分化生长抑素瘤
本文报告一例25岁男性1型神经纤维瘤病随访患者,因疑似高分化十二指肠神经内分泌肿瘤行68Ga-DOTATOC PET/CT,未见显著摄取,而补充18F-FDG PET/CT显示原发肿瘤及淋巴结中等18F-FDG摄取。组织学证实为高分化十二指肠神经内分泌肿瘤,符合生长抑素瘤诊断。
要点
- 高分化生长抑素瘤可表现为生长抑素受体PET/CT假阴性。
- 68Ga-DOTATOC PET/CT未见显著摄取时,18F-FDG PET/CT可显示中等摄取。
- 高分化神经内分泌肿瘤虽罕见,仍应警惕其为生长抑素受体PET/CT假阴性的可能来源。
核心结论
- 高分化神经内分泌肿瘤虽罕见,仍应警惕其为生长抑素受体PET/CT假阴性的可能来源。
研究设计与样本
- 个案报告:一例25岁男性1型神经纤维瘤病随访患者。
主要发现
- 68Ga-DOTATOC PET/CT未见显著摄取。
- 补充18F-FDG PET/CT显示原发肿瘤及淋巴结中等18F-FDG摄取。
- 组织学证实为高分化十二指肠神经内分泌肿瘤,符合生长抑素瘤诊断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We report the case of a 25-year-old man who was undergoing follow-up for neurofibromatosis type 1. The man underwent 68 Ga-DOTATOC PET/CT for a suspected well-differentiated duodenal neuroendocrine tumor. This examination did not reveal any significant uptake, whereas complementary 18 F-FDG PET/CT showed moderate 18 F-FDG uptake in the primary tumor as well as the adenopathy. Histology, a well-differentiated duodenal neuroendocrine tumor was confirmed, consistent with the diagnosis of somatostatinoma. Although rare, this well-differentiated neuroendocrine tumor should be kept in mind as a possible source of false-negative somatostatin receptor PET/CT findings.
引用
- Moreau A, Chaouat C, Walter T, et al. False-Negative Neuroendocrine Tumor Identified With 68 Ga-DOTATOC PET/CT : A Case of Well-Differentiated Somatostatinoma. Clin Nucl Med. 2024. PMID: 38689443. doi:10.1097/RLU.0000000000005241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。